In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Liminatus Pharma Inc (NASDAQ: LIMN) closed the day trading at $9.48 down -42.89% from the previous closing price of $16.6. In other words, the price has decreased by -$42.89 from its previous closing price. On the day, 0.65 million shares were traded. LIMN stock price reached its highest trading level at $17.55 during the session, while it also had its lowest trading level at $9.0.
Ratios:
For a better understanding of LIMN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.00 and its Current Ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 246618400.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.75, which has changed by 0.17910445 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $4.40. The 50-Day Moving Average of the stock is -10.85%, while the 200-Day Moving Average is calculated to be -11.52%.
Shares Statistics:
Over the past 3-months, LIMN traded about 300.81K shares per day on average, while over the past 10 days, LIMN traded about 381230 shares per day. A total of 26.01M shares are outstanding, with a floating share count of 5.40M. Insiders hold about 23.72% of the company’s shares, while institutions hold 1.75% stake in the company. Shares short for LIMN as of 1749772800 were 13758 with a Short Ratio of 0.16, compared to 1747267200 on 9549.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
